Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,720.00
Bid: 2,716.00
Ask: 2,718.00
Change: -22.00 (-0.80%)
Spread: 2.00 (0.074%)
Open: 2,746.00
High: 2,754.00
Low: 2,714.00
Prev. Close: 2,742.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supplementary Base Prospectus dated November 11, 2

11 Nov 2014 13:32

RNS Number : 7275W
Coca-Cola HBC Finance B.V.
11 November 2014
 



 

Coca-Cola HBC Finance B.V.

Guaranteed by Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V.

announce the publication of supplementary prospectus relating to the

EUR 3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V.

 

 

Amsterdam The Netherlands - November 11, 2014 - Coca-Cola HBC Finance B.V., Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V. announce today the publication of the following supplementary prospectus which has been approved by the UK Listing Authority and is available for viewing:

 

Supplementary Prospectus, dated November 11, 2014 to the Base Prospectus dated September 18, 2014, in respect of the €3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V. as issuer and Coca-Cola HBC A.G. and Coca-Cola HBC Holdings B.V. as guarantors (the "Supplementary Prospectus").

 

The Supplementary Prospectus constitutes a supplement for the purposes of Section 87G of the Financial Services and Markets Act 2000 (the "FSMA").This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus dated September 18, 2014. Terms defined in the Base Prospectus have the same meaning when used in this Supplement. The purpose of this Supplement is to incorporate by reference in the Base Prospectus the CCH Group's third quarter results for the period ended 26 September 2014 (the "CCH Group Results").

 

Copies of the CCH Group Results have been filed with the Financial Conduct Authority and, by virtue of this Supplement, the CCH Group Results are incorporated in, and form part of, the Base Prospectus, save that the ninth paragraph on page twelve of the CCH Group Results shall not be deemed to be incorporated in and shall not be deemed to form part of this Supplement.

 

A copy of the Supplementary Prospectus and the CCH Group Results have also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBBBJTMBTBBLI
Date   Source Headline
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding
15th Mar 20232:38 pmRNSDirector/PDMR Shareholding
8th Mar 202310:46 amRNSHolding(s) in Company
7th Mar 202311:56 amRNSHolding(s) in Company
6th Mar 20233:29 pmRNSDirector/PDMR Shareholding
3rd Mar 20238:00 amRNSDirector/PDMR Shareholding
1st Mar 20232:11 pmRNSIssue of equity and total voting rights
28th Feb 20238:09 amRNSDirector/PDMR Shareholding
23rd Feb 20239:21 amRNSDirector/PDMR Shareholding
22nd Feb 20233:54 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.